Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ECULIZUMAB 300 MG/30ML IV SOLN (NDC 25682000101) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 4, 2026 , from http://ppman.hank.ai/transparency/procedure/25682000101/by-state?code_type=NDC
“ECULIZUMAB 300 MG/30ML IV SOLN (NDC 25682000101) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/25682000101/by-state?code_type=NDC. Accessed
November 4, 2026 .
“ECULIZUMAB 300 MG/30ML IV SOLN (NDC 25682000101) by State,” HANK Price Transparency ,
accessed November 4, 2026 ,
http://ppman.hank.ai/transparency/procedure/25682000101/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
25682000101 — Eculizumab 300 Mg/30ml IV Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$13,808
National median
$9,787 – $31,310
IQR (p25 – p75)
31
hospitals filing
12
states
Walking in without insurance?
Cash / self-pay price
Cash median
$10,763
vs. negotiated
-22.1%
Hospitals reporting
53
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 25682000101 (NDC), with interquartile range
State Median p25 p75
KY $31,310 $31,310 $31,310
MA $31,310 $31,310 $31,310
ND $31,310 $31,310 $31,310
MI $29,656 $11,159 $44,450
NY $28,766 $27,397 $46,574
MO $26,907 $11,014 $28,701
NJ $23,727 $9,284 $36,503
MD $15,061 $14,408 $15,714
CA $14,191 $12,720 $31,310
AL $12,720 $9,489 $17,172
OH $11,506 $8,135 $13,808
OR $86 $40 $95